144 related articles for article (PubMed ID: 15163187)
1. Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1.
Dettin M; Pasquato A; Scarinci C; Zanchetta M; De Rossi A; Di Bello C
J Med Chem; 2004 Jun; 47(12):3058-64. PubMed ID: 15163187
[TBL] [Abstract][Full Text] [Related]
2. The role of positively charged residues in CXCR4 recognition probed with synthetic peptides.
Luo Z; Zhou N; Luo J; Hall JW; Huang Z
Biochem Biophys Res Commun; 1999 Oct; 263(3):691-5. PubMed ID: 10512741
[TBL] [Abstract][Full Text] [Related]
3. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
Mbemba E; Benjouad A; Saffar L; Gattegno L
Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
[TBL] [Abstract][Full Text] [Related]
4. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
[TBL] [Abstract][Full Text] [Related]
5. SDF-1-induced activation of ERK enhances HIV-1 expression.
Montes M; Tagieva NE; Heveker N; Nahmias C; Baleux F; Trautmann A
Eur Cytokine Netw; 2000 Sep; 11(3):470-7. PubMed ID: 11022134
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants of unexpected agonist activity in a retro-peptide analogue of the SDF-1alpha N-terminus.
Palladino P; Tizzano B; Pedone C; Ragone R; Rossi F; Saviano G; Tancredi T; Benedetti E
FEBS Lett; 2005 Oct; 579(24):5293-8. PubMed ID: 16182292
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
Hegde R; Borkow G; Berchanski A; Lapidot A
FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
[TBL] [Abstract][Full Text] [Related]
8. Solution studies of recombinant human stromal-cell-derived factor-1.
Holmes WD; Consler TG; Dallas WS; Rocque WJ; Willard DH
Protein Expr Purif; 2001 Apr; 21(3):367-77. PubMed ID: 11281710
[TBL] [Abstract][Full Text] [Related]
9. Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha.
Gozansky EK; Louis JM; Caffrey M; Clore GM
J Mol Biol; 2005 Jan; 345(4):651-8. PubMed ID: 15588815
[TBL] [Abstract][Full Text] [Related]
10. Peptide-lead CXCR4 antagonists with high anti-HIV activity.
Fujii N; Tamamura H
Curr Opin Investig Drugs; 2001 Sep; 2(9):1198-202. PubMed ID: 11717804
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.
Heveker N; Montes M; Germeroth L; Amara A; Trautmann A; Alizon M; Schneider-Mergener J
Curr Biol; 1998 Mar; 8(7):369-76. PubMed ID: 9545196
[TBL] [Abstract][Full Text] [Related]
12. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
[TBL] [Abstract][Full Text] [Related]
13. Attachment of C-terminus of SDF-1 enhances the biological activity of its N-terminal peptide.
Luo J; Luo Z; Zhou N; Hall JW; Huang Z
Biochem Biophys Res Commun; 1999 Oct; 264(1):42-7. PubMed ID: 10527838
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments.
Imai M; Baranyi L; Okada N; Okada H
Biochem Biophys Res Commun; 2007 Feb; 353(4):851-6. PubMed ID: 17210123
[TBL] [Abstract][Full Text] [Related]
17. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
[TBL] [Abstract][Full Text] [Related]
18. Identification of a D-amino acid decapeptide HIV-1 entry inhibitor.
Boggiano C; Jiang S; Lu H; Zhao Q; Liu S; Binley J; Blondelle SE
Biochem Biophys Res Commun; 2006 Sep; 347(4):909-15. PubMed ID: 16854380
[TBL] [Abstract][Full Text] [Related]
19. Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells.
Geeraerts T; Deiva K; M'sika I; Salim H; Héry C; Tardieu M
Neurosci Lett; 2006 May; 399(1-2):115-20. PubMed ID: 16481105
[TBL] [Abstract][Full Text] [Related]
20. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
